Tilray Brands, Inc. Operating Lease, Expense
Tilray Brands, Inc. (TLRY) reported Operating Lease, Expense of $4.98 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-07-28
- Tilray Brands, Inc. operating lease, expense for the quarter ending 2026-05-31 was $2.12M, a 413.59% increase year-over-year.
- Tilray Brands, Inc. operating lease, expense for the quarter ending 2026-02-28 was $782.00K, a 7.71% increase year-over-year.
- Tilray Brands, Inc. operating lease, expense for the quarter ending 2025-11-30 was $1.20M, a 14.34% increase year-over-year.
- Tilray Brands, Inc. operating lease, expense for the quarter ending 2025-08-31 was $886.00K, a 30.18% decline year-over-year.
- Tilray Brands, Inc. operating lease, expense for fiscal 2026 was $4.98M, a 44.22% increase from fiscal 2025.
- Tilray Brands, Inc. operating lease, expense for fiscal 2025 was $3.45M, a 24.69% decline from fiscal 2024.
- Tilray Brands, Inc. operating lease, expense for fiscal 2024 was $4.58M, a 45.32% increase from fiscal 2023.
- Tilray Brands, Inc. operating lease, expense for fiscal 2023 was $3.15M, a 16.11% decline from fiscal 2022.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2026-05-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $2.90M derived: sum of 2 quarters · filed 2026-07-28 | $4.09M derived: sum of 3 quarters · filed 2026-07-28 | $4.98M 10-K · filed 2026-07-28 |
| 2026-02-28 | $782.00K 10-Q · filed 2026-04-01 | $1.98M derived: sum of 2 quarters · filed 2026-04-01 | $2.86M 10-Q · filed 2026-04-01 | $3.28M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-11-30 | $1.20M 10-Q · filed 2026-01-08 | $2.08M 10-Q · filed 2026-01-08 | $2.49M derived: sum of 3 quarters · filed 2026-07-28 | $3.22M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-08-31 | $886.00K 10-Q · filed 2025-10-09 | $1.30M derived: sum of 2 quarters · filed 2026-07-28 | $2.02M derived: sum of 3 quarters · filed 2026-07-28 | $3.07M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-05-31 | $412.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $1.14M derived: sum of 2 quarters · filed 2026-07-28 | $2.18M derived: sum of 3 quarters · filed 2026-07-28 | $3.45M 10-K · filed 2026-07-28 |
| 2025-02-28 | $726.00K 10-Q · filed 2026-04-01 | $1.77M derived: sum of 2 quarters · filed 2026-04-01 | $3.04M 10-Q · filed 2026-04-01 | $4.17M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-11-30 | $1.05M 10-Q · filed 2026-01-08 | $2.31M 10-Q · filed 2026-01-08 | $3.44M derived: sum of 3 quarters · filed 2026-07-28 | $4.47M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-08-31 | $1.27M 10-Q · filed 2025-10-09 | $2.40M derived: sum of 2 quarters · filed 2026-07-28 | $3.42M derived: sum of 3 quarters · filed 2026-07-28 | $5.00M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-05-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $2.15M derived: sum of 2 quarters · filed 2026-07-28 | $3.73M derived: sum of 3 quarters · filed 2026-07-28 | $4.58M 10-K · filed 2026-07-28 |
| 2024-02-29 | $1.02M 10-Q · filed 2025-04-08 | $2.60M derived: sum of 2 quarters · filed 2025-04-08 | $3.46M 10-Q · filed 2025-04-08 | $4.22M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-11-30 | $1.57M 10-Q · filed 2025-01-10 | $2.43M 10-Q · filed 2025-01-10 | $3.20M derived: sum of 3 quarters · filed 2025-07-29 | $3.98M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-08-31 | $858.00K 10-Q · filed 2024-10-10 | $1.63M derived: sum of 2 quarters · filed 2025-07-29 | $2.41M derived: sum of 3 quarters · filed 2025-07-29 | $3.15M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-05-31 | $768.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $1.55M derived: sum of 2 quarters · filed 2025-07-29 | $2.29M derived: sum of 3 quarters · filed 2025-07-29 | $3.15M 10-K · filed 2025-07-29 |
| 2023-02-28 | $782.00K 10-Q · filed 2024-04-09 | $1.52M derived: sum of 2 quarters · filed 2024-04-09 | $2.39M 10-Q · filed 2024-04-09 | $2.97M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-11-30 | $740.00K 10-Q · filed 2024-01-09 | $1.60M 10-Q · filed 2024-01-09 | $2.19M derived: sum of 3 quarters · filed 2024-10-10 | $4.31M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-08-31 | $865.00K 10-Q · filed 2024-10-10 | $1.45M derived: sum of 2 quarters · filed 2024-10-10 | $3.57M derived: sum of 3 quarters · filed 2024-10-10 | $3.86M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-05-31 | $584.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $2.70M derived: sum of 2 quarters · filed 2024-07-30 | $3.00M derived: sum of 3 quarters · filed 2024-07-30 | $3.76M 10-K · filed 2024-07-30 |
| 2022-02-28 | $2.12M 10-Q · filed 2023-04-10 | $2.41M derived: sum of 2 quarters · filed 2023-04-10 | $3.18M 10-Q · filed 2023-04-10 | $4.23M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-11-30 | $292.00K 10-Q · filed 2023-01-09 | $1.06M 10-Q · filed 2023-01-09 | $2.11M derived: sum of 3 quarters · filed 2023-07-26 | $2.79M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-08-31 | $766.00K 10-Q · filed 2022-10-07 | $1.82M derived: sum of 2 quarters · filed 2023-07-26 | $2.50M derived: sum of 3 quarters · filed 2023-07-26 | |
| 2021-05-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $1.73M derived: sum of 2 quarters · filed 2023-07-26 | $2.20M 10-K · filed 2023-07-26 | |
| 2021-02-28 | $678.00K 10-Q · filed 2022-04-06 | $1.15M 10-Q · filed 2022-04-06 | ||
| 2020-05-31 | $1.97M 10-K · filed 2022-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |